Clinical Trials Logo
  1. Home
  2. Chronic Heart Failure
  3. NCT00984529
  4. Details
NCT00984529 Clinical Trial

Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

Chronic Heart Failure Clinical Trial

Official title:
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00984529
Other study ID # NIS-CHR-ATA-2008/1
Secondary ID
Status Completed
Phase N/A
First received September 24, 2009
Last updated January 6, 2011
Start date September 2009
Est. completion date February 2010

Study information
Verified date January 2011
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Croatia: Ethics CommitteeCroatia: Ministry of Health and Social Care
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.

Recruitment information / eligibility
Status Completed
Enrollment 500
Est. completion date February 2010
Est. primary completion date February 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with diagnosed chronic heart failure

- Patients treated for at least 6 months with candesartan cilexetil

- Signed Informed consent

Exclusion Criteria:

- Hypersensitivity to candesartan cilexetil

- Pregnancy / lactation

- Severe hepatic impairment

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
Croatia Research Site Biograd
Croatia Research Site Bjelovar
Croatia Reserach Site Cakovec
Croatia Research Site Karlovac
Croatia Reserach Site Krapinske Toplice
Croatia Research Site Novi Marof
Croatia Research Site Opatija
Croatia Research Site Osijek
Croatia Research Site Pula
Croatia Research Site Rijeka
Croatia Reserach Site Sl. Brod
Croatia Research Site Split
Croatia Research Site Stubicke Toplice
Croatia Reserach Site Zabok
Croatia Research Site Zagreb

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Croatia, 

Outcome
Type Measure Description Time frame Safety issue
Primary To evaluate clinical signs and symptoms of chronic heart failure (in terms of NYHA status, fluid retention and tiredness/fatigue) after at least 6 months of treatment with candesartan cilexetil 1 visit (after at least 6 months of treatment) No
Secondary To evaluate ventricular function after at least 6 months of treatment with candesartan cilexetil 1 visit (after at least 6 months of treatment) No
Secondary To gain insight into usage of candesartan cilexetil in real life for chronic heart failure in Croatia 1 visit (after at least 6 months of treatment) No
Secondary To evaluate patient`s compliance with prescribed treatment 1 visit (after at least 6 months of treatment) No
See also
  Status Clinical Trial Phase
Completed NCT03597646 - The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure N/A
Terminated NCT04065997 - Apogee International
Withdrawn NCT03675113 - Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure N/A
Completed NCT02916160 - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study Phase 4
Completed NCT03126656 - Effects of Testosterone on Myocardial Repolarization Phase 4
Completed NCT02268500 - VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) Phase 4
Completed NCT02247245 - The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients. N/A
Terminated NCT01906957 - Cognition and Exercise Training N/A
Completed NCT01919918 - Muscle Afferent Feedback Effects in Patients With Heart Failure Phase 1
Not yet recruiting NCT01669395 - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT02840565 - Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 Phase 1
Completed NCT02441218 - Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study Phase 3
Completed NCT00149409 - Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure Phase 2/Phase 3
Terminated NCT05532046 - A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT) Phase 1
Recruiting NCT04984928 - Readmission Risk of Patients With Heart Failure.
Completed NCT02814097 - A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction Phase 2
Active, not recruiting NCT05560737 - ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I
Not yet recruiting NCT06002321 - Right Ventricular Dysfunction in Chronic Heart Failure